Article
Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder.
The pharmacogenomics journal - 1 Dec 2008
Tsai S-J, Liou Y-J, Hong C-J, Yu Y W-Y, Chen T-J
Abstract excerpt
Evidence suggests that glycogen synthase kinase-3beta (GSK3B) activity is increased significantly in the brain of patients with major depressive disorders (MDD). Inhibition of GSK3B is thought to be a key feature in the therapeutic mechanism of antidepressants. To investigate whether common genetic variants in the GSK3B gene are associated with MDD and the therapeutic response to antidepressants, four...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
